|
|
 |
|
Viewing report
|
|
|
|
Drug Delivery Innovations Driving Improved Patient Compliance
Business Insights, July 2011, Pages: 147
This report gives in depth coverage of the factors driving patient non compliance. The report then goes on to describe and analyse key technologies being developed to improve compliance in the oral and parenteral delivery spaces. Finally the report looks at new delivery devices being developed which will improve patient compliance.
Features and benefits
- Understand the causes of poor patient compliance and the technologies that are already in use to overcome these causes.
- Assess key innovative modified release oral delivery technologies that are in development.
- Assess key innovative modified release parenteral technologies that are in development.
- Assess key innovative drug delivery devices that are in development and understand how they can improve patient compliance and for which indications.
Highlights
The importance of the oral route of administration from both a clinician and patient acceptance point of view means there has been a vast amount of development and research in drug delivery via this route. Noncompliance can be attributed to poor taste, difficulty in administration or swallowing, and the inconvenience of multiple doses per day.
Of all the modifications to parenteral delivery systems, the transdermal administration route is attracting the most attention. Across all parenteral delivery forms, the continued increase in the number of experimental protein and peptide drug candidates means that there is a high level of unmet need for delivery systems for these types of drugs.
Pharmaceutical devices will continue to drive patient compliance and acceptability as increased options make for a wider choice. The convergence of MEMS and nanotechnology with biological applications offers breakthrough in drug developments.
Your key questions answered
- What new technologies are being developed to improve patient compliance?
- Which companies are the leaders in the development of new delivery technologies aimed at improving compliance?
- What technologies in development can be applied to the specific therapy areas that my company is involved in?
- How will new technologies drive improvements in patient compliance?
- What new devices are in development that we could license to deliver our pipeline products?
|
|
|
|
